Jacksonville South: 904-281-5757 | Jacksonville UNC: 904-281-5757 | Memphis: 901-843-1045 | Orlando Downtown: 407-425-5100 |
Orlando SODO: 407-722-5313
Jacksonville: 904-281-5757 | Memphis: 901-843-1045
Downtown Orlando: 407-425-5100 | Orlando SODO: 407-425-5100
Located conveniently in the Thornton Park/Lake Eola district at the corner of South Street and Summerlin Avenue in the GAI Building. Free parking is available in the attached parking garage.
As always, our services are free of charge. Compensation is provided to all clinical trial participants along with a diagnostic work-up and comprehensive physical exam at no cost.
It’s easy to see if you qualify with a free 30-minute appointment at our Orlando, FL office – located in Downtown Orlando, a couple of blocks from Lake Eola.
Use the form on this page to schedule your free appointment. No health insurance is needed and there is no need for a referral.
Our Orlando location opened it’s doors in 1996 and has conducted hundreds of clinical trials which have led to the approval of many new medications.
EDC Research Assistant
Senior Project Manager/Rater
Senior Project Manager/Rater/Staff Development Manager
Regulatory/QA Specialist
Lab Manager
Research Assistant
CRC
Intake Specialist
Regulatory/QA Specialist
Senior Project Manager/Rater
Prescreener
CRC/Rater
Study Coordinator/ Therapist/Rater
Research Assistant
CRC
CRC/Rater
Research Assistant
Senior Project Manager/Clinical Research Nurse
CCRC
CRC
Front Desk/Research Assistant
618 E. South St. Suite 100 Orlando, FL 32801
Call Us: (407) 425-5100
Email Us: orlinfo@cnshealthcare.com
Since opening our doors in 1996, CNS Healthcare has had the privilege of assisting in the development of some of the most widely prescribed medicines in the world. We continue to lead the way in providing the clinical research necessary to identify medications for the FDA to review and, once approved, physicians to prescribe. CNS has conducted thousands of clinical trials, improved millions of lives, and is proud to have helped in the FDA approval of nearly 100 new treatments.